Review Volume 12, Issue 22 pp 23379—23393
Radiation-induced skin injury: pathogenesis, treatment, and management
- 1 Department of Radiation Oncology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
- 2 Department of Orthopedics, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center, Shanghai, China
- 3 Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
- 4 Shanghai Medical College, Fudan University, Shanghai, China
- 5 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Received: May 10, 2020 Accepted: July 30, 2020 Published: November 16, 2020https://doi.org/10.18632/aging.103932
How to Cite
Copyright: © 2020 Yang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Radiation-induced skin injury (RSI) refers to a frequently occurring complication of radiation therapy. Nearly 90% of patients having received radiation therapy underwent moderate-to-severe skin reactions, severely reducing patients' quality of life and adversely affecting their disease treatment. No gold standard has been formulated for RSIs. In the present study, the mechanism of RSI and topical medications was discussed. Besides, this study can be referenced for clinicians to treat RSIs to guide subsequent clinical medicine.